A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 197 participants.
Also called NCT01945684
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 197 participants
- Registry
-
NCT01945684
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01945684. Randomized; triple masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2014-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity
- Condition
- Spasticity
- Condition
- Stroke
- Intervention (Drug)
- Botulinum toxin type A
- Lead sponsor
- Daewoong Pharmaceutical Co. LTD.
Record details
- Record id
cardio:ct-nct01945684- Content hash
399aaae9e4aa31c55b7a2ce431e5c932d652466a1369dad13e14bc23fa484138